Imagine living with chronic pain for years, with the nearest cannabis-specialist doctor a two-hour drive away, where the journey itself triggers fresh symptoms. In situations like this, a cannabis video consultation in Switzerland is more than a convenient alternative. It is the very condition that makes medical cannabis therapy accessible to you in the first place.
This guide explains what a video consultation is in legal terms, how the process actually unfolds, what the doctor can and cannot see on the screen, and what happens to your data.
What is a cannabis video consultation, and is it legally allowed?
A video consultation is a synchronous medical appointment that you and the doctor attend at the same time over a video link. Unlike a simple online questionnaire, a real conversation takes place: the doctor sees you, hears your voice, can ask follow-up questions, and you can read their reactions. This format has been established in Switzerland for years and is explicitly recognised in Article 16 of the FMH professional code as a permitted form of medical care, provided the physician’s duty of care remains as high as it would be in person.
For prescribing medical cannabis, an additional legal frame comes from the revised Narcotics Act. Since 1 August 2022, any Swiss doctor may prescribe cannabis medicines without a special authorisation from the Swiss Federal Office of Public Health (FOPH/BAG) [Source: FOPH, Medical Use of Cannabis, 2025]. This legal change concerns the prescribing power itself, not any particular consultation format. A cannabis video consultation is therefore on the same legal footing as an in-person visit, as long as the medical assessment is based on sufficient information.
In plain terms: a Swiss cannabis video consultation is not a legal workaround or a loophole. It is a fully recognised form of medical care, held to the same quality standard as a practice visit.
How does a Swiss cannabis video consultation actually work?
A typical cannabis video consultation breaks down into clear, sequential steps. Step one is the online intake: you fill in a structured questionnaire about your symptoms, previous therapies, current medications, and pre-existing conditions. Ideally you also upload relevant medical documents, for example reports from your GP, MRI findings, lab values, or treatment protocols from earlier therapies. This information is especially valuable in telemedicine because it forms the basis for the doctor’s later decision.
Step two is booking. Most Swiss telemedicine platforms offer self-service online scheduling, where you choose a free slot. Step three is the first consultation itself, which typically lasts 30 to 45 minutes. The doctor reviews your intake, asks targeted follow-up questions, evaluates your descriptions, and decides with you whether cannabis therapy is indicated and which form is appropriate. For background on the product options, see our guide to medical cannabis products.
Step four is the prescription. If indication is confirmed, the doctor issues a narcotic prescription form (known in Switzerland as Betm-Rezept). This prescription is currently still mostly sent physically in Switzerland, although digital channels to specialised pharmacies are increasingly available. Step five is the duration of therapy. Because a Betm-Rezept is valid for a maximum of three months, regular follow-ups are built in. Over a year that means at least four consultations, in which efficacy, dose, and tolerability are reviewed and adjusted as needed. For more on the legal framework, see Cannabis Prescription Switzerland 2026.
What the doctor sees on a cannabis video consultation, and what they don’t
An honest assessment of what is and isn’t possible matters here. In a cannabis video consultation the doctor sees a range of clinically relevant signals: skin colour, facial expression, posture, speech, cognitive clarity, emotional state. They can roughly assess your musculoskeletal function by asking you to demonstrate a specific movement. They can place pain descriptions in context, because expression and tone of voice tend to confirm or temper the intensity that you describe.
What they cannot do directly: palpation, auscultation, blood pressure measurement, abdominal examination, neurological reflex testing. These limits are real, and they are why pre-existing medical reports carry more weight in a telemedicine consultation than they would in an in-person first visit. If your GP has already worked through a thorough diagnostic process, the cannabis video consultation will pick up those findings and decide on therapy on top of an already established diagnosis. If no such diagnostic foundation exists, the specialist will often send you back to your GP for a workup before cannabis therapy comes into consideration.
In concrete terms, there are situations where a video consultation is not the right format. An acute pain crisis, suspicion of an as-yet-unexplained new condition, or an unstable comorbidity belong in the practice or in emergency care. Telemedicine is an extension of the care offering, not a replacement for emergency medicine.
Want to learn more about how cannabis therapy is structured and which treatment options might suit your situation? Speak with our specialist.
Data protection: what happens to my health data?
Health data falls into Switzerland’s category of specially protected personal data. The revised Federal Act on Data Protection (Bundesgesetz über den Datenschutz, FADP / DSG), in force since September 2023, defines this in Article 5 lit. c and imposes higher requirements on its processing. For you as a patient this means comprehensive protection that applies regardless of whether you are seen in a practice or via cannabis video consultation.
Concretely, the telemedicine platform must put organisational and technical safeguards in place to protect your data from unauthorised access. Most Swiss providers host their infrastructure in Switzerland or the European Economic Area, encrypt the video connection end to end, and strictly limit data access to the medical staff involved in your care.
A frequent question concerns recording of the call. The honest answer: reputable providers do not record video consultations. What remains after a session is the doctor’s documentation in your medical record: diagnosis, treatment plan, prescribed medications, agreed follow-ups. This documentation is subject to medical confidentiality and to the retention periods set out in Swiss medical professional law. You retain the right to access, correction, and under certain conditions deletion of your data, governed by Articles 25 and following of the FADP.
A second important clarification concerns Swiss health insurers (Krankenkasse). Without your express consent, your treatment is not reported to your insurer. The exception is a written cost approval request (Kostengutsprache) under Article 71a of the Ordinance on Health Insurance Benefits (KVV), which you actively initiate yourself if you wish the treatment to be covered. In every other case, your cannabis therapy remains private medical information.
⚠ Important to know
A video consultation is not a substitute for emergency medical care. If you experience an acute deterioration, sudden severe symptoms, or signs of a serious illness, contact your GP directly or seek emergency care.
Cannabis medicines can interact with other drugs, particularly anticoagulants, certain antidepressants, and immunosuppressants. A complete list of your current medications is mandatory before your first appointment.
Switzerland enforces an analytical THC limit of 1.5 micrograms per litre of blood for road traffic. Patients on THC-containing therapy are generally not permitted to drive until an individual medical assessment of fitness to drive has been completed.
Cannabis video consultation: frequently asked questions
Is a cannabis video consultation legally equivalent to an in-person visit?
Yes, provided the physician’s duty of care is met to the same standard in both cases. Article 16 of the FMH professional code recognises telemedicine as a permitted form of medical care. The condition is that the doctor can make a sound medical assessment based on the information available. Your existing medical records are particularly valuable in this regard.
Can I get a prescription on the first cannabis video consultation?
Not guaranteed. A prescription is issued only when, after reviewing your records and during the consultation, the doctor concludes that cannabis therapy is medically indicated and safe for you. In some cases the doctor will request additional workup or supplementary reports before deciding.
Will my data be sent to my health insurer?
No, not without your express consent. Medical treatment is bound by physician confidentiality. Information is sent to your insurer only when you yourself initiate a written cost approval request, for example under Article 71a KVV in cases of serious illness. Otherwise, your cannabis therapy remains a private medical matter between you and your doctor.
Conclusion
A cannabis video consultation in Switzerland is neither a stopgap nor a legal grey zone. It is a fully recognised form of medical care, equal in quality and legal status to an in-person visit. What sets it apart is reachability for patients for whom travelling to a specialist is difficult for medical, professional, or geographical reasons. What it asks of you is full participation: meaningful prior reports, a clear description of your symptoms, and a complete medication history.
Patients who bring those elements receive in a cannabis video consultation the same medical attention as in a traditional practice, with the added benefit of receiving it from their own living room.
Want to learn more? Speak with our specialist.
Sources: Swiss Federal Office of Public Health (FOPH/BAG), Medical Use of Cannabis, 2025; FMH professional code (Art. 16, telemedicine provisions), 2024 revision; Federal Act on Data Protection (FADP/DSG), revised version in force since September 2023; Federal Act on the Electronic Patient Record (EPDG); Whiting PF et al., JAMA, 2015.
Note: This article is for general patient information and does not replace individual medical advice.
